Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Radiofrequency ablation of recurrent cholangiocarcinoma after orthotopic liver transplantation -- a case report.

Literature DB >> 15641158

Radiofrequency ablation of recurrent cholangiocarcinoma after orthotopic liver transplantation -- a case report.

Abstract

AIM: To report the use of radiofrequency ablation in the treatment of recurrent cholangiocarcinoma in the transplanted liver.
METHODS: A lady who underwent orthotopic liver transplantation (OLT) for intrahepatic cholangiocarcinoma recurrence of tumour 13 mo after transplantation inspite of adjuvant chemotherapy. Her recurrent tumour was treated with radiofrequency ablation.
RESULTS: She survived for 18 mo following the recurrence of her tumour.
CONCLUSION: Radiofrequency ablation can be used safely in the transplanted liver to treat recurrent tumour.

Entities: Disease

Mesh：

Year: 2005 PMID： 15641158 PMCID： PMC4250823 DOI： 10.3748/wjg.v11.i4.612

Source DB: PubMed Journal: World J Gastroenterol ISSN： 1007-9327 Impact factor: 5.742

11 in total

1. Surgical treatment of intrahepatic cholangiocarcinoma: four patients surviving more than five years.

Authors: J Yamamoto; T Kosuge; T Takayama; K Shimada; M Makuuchi; J Yoshida; M Sakamoto; S Hirohashi; S Yamasaki; H Hasegawa
Journal: Surgery Date: 1992-06 Impact factor: 3.982

Review 2. Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature.

Authors: M Shimoda; D G Farmer; S D Colquhoun; M Rosove; R M Ghobrial; H Yersiz; P Chen; R W Busuttil
Journal: Liver Transpl Date: 2001-12 Impact factor: 5.799

3. Intrahepatic cholangiocarcinoma.

Authors: K M Chu; E C Lai; S Al-Hadeedi; C E Arcilla; C M Lo; C L Liu; S T Fan; J Wong
Journal: World J Surg Date: 1997 Mar-Apr Impact factor: 3.352

Review 4. Radiofrequency ablation of primary and metastatic liver tumors.

Authors: Steven A Curley; Francesco Izzo
Journal: Surg Technol Int Date: 2002-09

5. Radiofrequency ablation of recurrent cholangiocarcinoma.

Authors: Douglas P Slakey
Journal: Am Surg Date: 2002-04 Impact factor: 0.688

6. Non-resective ablation and liver transplantation in patients with cirrhosis and hepatocellular carcinoma (HCC): safety and efficacy.

Authors: D Maluf; R A Fisher; T Maroney; A Cotterell; A Fulcher; J Tisnado; M Contos; V Luketic; R Stravitz; M Shiffman; R Sterling; M Posner
Journal: Am J Transplant Date: 2003-03 Impact factor: 8.086

7. Is liver transplantation indicated for cholangiocarcinoma?

Authors: R M Goldstein; M Stone; G W Tillery; N Senzer; M Levy; B S Husberg; T Gonwa; G Klintmalm
Journal: Am J Surg Date: 1993-12 Impact factor: 2.565

8. Surgical management of intrahepatic cholangiocarcinoma: a 31-year experience.

Authors: M J Lieser; M K Barry; C Rowland; D M Ilstrup; D M Nagorney
Journal: J Hepatobiliary Pancreat Surg Date: 1998

9. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study.

Authors: Tito Livraghi; Luigi Solbiati; M Franca Meloni; G Scott Gazelle; Elkan F Halpern; S Nahum Goldberg
Journal: Radiology Date: 2003-02 Impact factor: 11.105

4. Treatment of malignant liver tumors by radiofrequency ablation combined with low-frequency ultrasound radiation with microbubbles.

Authors: Ai Junhua; Jin Yun; Wang Zhenzhou; Yang Ling; Luo Ding
Journal: PLoS One Date: 2013-01-10 Impact factor: 3.240

4 in total